Valuation: Enimmune corporation

Market Cap 1.1B 34.71M 30.07M 28.38M 25.75M 48.3M 3.33B 48.65M 339M 131M 1.69B 130M 127M 5.36B P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 1.05B 32.99M 28.59M 26.98M 24.47M 45.91M 3.16B 46.24M 322M 124M 1.6B 124M 121M 5.1B EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
28.72%
Yield 2024 *
-
Yield 2025 -
1 day-0.33%
1 week-1.92%
Current month-6.99%
1 month-6.42%
3 months-11.56%
6 months-8.38%
Current year-25.73%
1 week 15.2
Extreme 15.2
15.95
1 month 15.2
Extreme 15.2
16.95
Current year 14.9
Extreme 14.9
22.15
1 year 14.9
Extreme 14.9
23.9
3 years 14.65
Extreme 14.65
49.3
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 06/01/2019
Chief Tech/Sci/R&D Officer - 20/07/2014
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Chairman - 06/01/2019
Director/Board Member - 01/01/2014
Director/Board Member - 18/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%-1.92%-24.63%-61.85% 34.71M
+5.04%+3.66%+50.62%+103.77% 70.24B
+1.64%-0.18%+34.67%+76.81% 62.63B
-3.18%-0.78%-14.14%+369.82% 27.36B
-0.28%-0.69%+26.06%+11.53% 25.71B
+2.20%-4.72%+2.19%-13.14% 24.83B
+1.15%-1.17%+17.56%-21.92% 19.52B
-7.03%-10.19%+161.91%+303.00% 15.51B
-3.33%-4.71%-8.64%+488.61% 14.66B
+4.96%+4.63%-2.75%+864.40% 14.69B
Average +0.07%-1.74%+24.28%+212.10% 27.52B
Weighted average by Cap. +1.28%-0.80%+31.80%+168.33%

Financials

2024 2025
Net sales 39.92M 1.26M 1.09M 1.03M 931K 1.75M 120M 1.76M 12.26M 4.72M 61.03M 4.71M 4.61M 194M 48.19M 1.52M 1.31M 1.24M 1.12M 2.11M 145M 2.12M 14.8M 5.7M 73.69M 5.69M 5.57M 234M
Net income -158M -4.95M -4.29M -4.05M -3.68M -6.89M -475M -6.94M -48.38M -18.64M -241M -18.61M -18.2M -766M -164M -5.17M -4.48M -4.23M -3.83M -7.19M -495M -7.24M -50.47M -19.45M -251M -19.41M -18.98M -799M
Net Debt -382M -12.01M -10.41M -9.82M -8.91M -16.72M -1.15B -16.84M -117M -45.21M -584M -45.12M -44.13M -1.86B -54.59M -1.72M -1.49M -1.4M -1.27M -2.39M -165M -2.41M -16.77M -6.46M -83.48M -6.45M -6.31M -265M
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
14/09/26 NT$15.30 -0.33% 35,327
11/09/26 NT$15.35 -3.76% 86,364
10/09/26 NT$15.95 +2.90% 64,907
09/09/26 NT$15.50 +0.32% 18,506
08/09/26 NT$15.45 -0.96% 60,262
  1. Stock Market
  2. Stocks
  3. 6564 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!